BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37559362)

  • 1. The LDL receptor is regulated by membrane cholesterol as revealed by fluorescence fluctuation analysis.
    Morales SV; Mahmood A; Pollard J; Mayne J; Figeys D; Wiseman PW
    Biophys J; 2023 Sep; 122(18):3783-3797. PubMed ID: 37559362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of reduced low-density lipoprotein receptor level on HepG2 cell cholesterol metabolism.
    Izem L; Rassart E; Kamate L; Falstrault L; Rhainds D; Brissette L
    Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):81-9. PubMed ID: 9405278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol-dependent anaplasma phagocytophilum exploits the low-density lipoprotein uptake pathway.
    Xiong Q; Lin M; Rikihisa Y
    PLoS Pathog; 2009 Mar; 5(3):e1000329. PubMed ID: 19283084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adaptor protein beta-arrestin2 enhances endocytosis of the low density lipoprotein receptor.
    Wu JH; Peppel K; Nelson CD; Lin FT; Kohout TA; Miller WE; Exum ST; Freedman NJ
    J Biol Chem; 2003 Nov; 278(45):44238-45. PubMed ID: 12944399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptor protein ARH is recruited to the plasma membrane by low density lipoprotein (LDL) binding and modulates endocytosis of the LDL/LDL receptor complex in hepatocytes.
    Sirinian MI; Belleudi F; Campagna F; Ceridono M; Garofalo T; Quagliarini F; Verna R; Calandra S; Bertolini S; Sorice M; Torrisi MR; Arca M
    J Biol Chem; 2005 Nov; 280(46):38416-23. PubMed ID: 16129683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IDOL stimulates clathrin-independent endocytosis and multivesicular body-mediated lysosomal degradation of the low-density lipoprotein receptor.
    Scotti E; Calamai M; Goulbourne CN; Zhang L; Hong C; Lin RR; Choi J; Pilch PF; Fong LG; Zou P; Ting AY; Pavone FS; Young SG; Tontonoz P
    Mol Cell Biol; 2013 Apr; 33(8):1503-14. PubMed ID: 23382078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The modular adaptor protein autosomal recessive hypercholesterolemia (ARH) promotes low density lipoprotein receptor clustering into clathrin-coated pits.
    Garuti R; Jones C; Li WP; Michaely P; Herz J; Gerard RD; Cohen JC; Hobbs HH
    J Biol Chem; 2005 Dec; 280(49):40996-1004. PubMed ID: 16179341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-density lipoprotein receptor is a calcium/magnesium sensor - role of LR4 and LR5 ion interaction kinetics in low-density lipoprotein release in the endosome.
    Martínez-Oliván J; Rozado-Aguirre Z; Arias-Moreno X; Angarica VE; Velázquez-Campoy A; Sancho J
    FEBS J; 2014 Jun; 281(11):2638-58. PubMed ID: 24720672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The LXR-IDOL axis defines a clathrin-, caveolae-, and dynamin-independent endocytic route for LDLR internalization and lysosomal degradation.
    Sorrentino V; Nelson JK; Maspero E; Marques ARA; Scheer L; Polo S; Zelcer N
    J Lipid Res; 2013 Aug; 54(8):2174-2184. PubMed ID: 23733886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clathrin adaptor proteins ARH, Dab2, and numb play distinct roles in Niemann-Pick C1-Like 1 versus low density lipoprotein receptor-mediated cholesterol uptake.
    Wei J; Fu ZY; Li PS; Miao HH; Li BL; Ma YT; Song BL
    J Biol Chem; 2014 Nov; 289(48):33689-700. PubMed ID: 25331956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of the LDL receptors by PCSK9 is not mediated by a secreted protein acted upon by PCSK9 extracellularly.
    Holla ØL; Cameron J; Berge KE; Ranheim T; Leren TP
    BMC Cell Biol; 2007 Mar; 8():9. PubMed ID: 17328821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic deletion of low density lipoprotein receptor impairs sterol-induced mouse macrophage ABCA1 expression. A new SREBP1-dependent mechanism.
    Zhou X; He W; Huang Z; Gotto AM; Hajjar DP; Han J
    J Biol Chem; 2008 Jan; 283(4):2129-38. PubMed ID: 18029360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adaptor protein Dab2 sorts LDL receptors into coated pits independently of AP-2 and ARH.
    Maurer ME; Cooper JA
    J Cell Sci; 2006 Oct; 119(Pt 20):4235-46. PubMed ID: 16984970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a VLDL-induced, FDNPVY-independent internalization mechanism for the LDLR.
    Michaely P; Zhao Z; Li WP; Garuti R; Huang LJ; Hobbs HH; Cohen JC
    EMBO J; 2007 Jul; 26(14):3273-82. PubMed ID: 17581630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor.
    Zelcer N; Hong C; Boyadjian R; Tontonoz P
    Science; 2009 Jul; 325(5936):100-4. PubMed ID: 19520913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol in LDL receptor recycling and degradation.
    Yang HX; Zhang M; Long SY; Tuo QH; Tian Y; Chen JX; Zhang CP; Liao DF
    Clin Chim Acta; 2020 Jan; 500():81-86. PubMed ID: 31770510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disabled-2 colocalizes with the LDLR in clathrin-coated pits and interacts with AP-2.
    Morris SM; Cooper JA
    Traffic; 2001 Feb; 2(2):111-23. PubMed ID: 11247302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The modular adaptor protein ARH is required for low density lipoprotein (LDL) binding and internalization but not for LDL receptor clustering in coated pits.
    Michaely P; Li WP; Anderson RG; Cohen JC; Hobbs HH
    J Biol Chem; 2004 Aug; 279(32):34023-31. PubMed ID: 15166224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human prostate cancer cells lack feedback regulation of low-density lipoprotein receptor and its regulator, SREBP2.
    Chen Y; Hughes-Fulford M
    Int J Cancer; 2001 Jan; 91(1):41-5. PubMed ID: 11149418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.